Objective: To compare the longitudinal effects of single-vision spectacles (SV) and orthokeratology (OK) lenses on choroidal structure and microcirculation in adolescents with myopia, and to analyze differences in responses between the two correction modalities. Methods: This prospective, nonrandomized cohort study enrolled myopic patients aged 8 to 15 years. Axial length (AL), spherical equivalent refraction (SE), choroidal thickness (ChT), and three-dimensional choroidal vascularity index (3D-CVI) in nine macular sectors within concentric rings of 1, 3, and 6 mm in diameter were measured at baseline and at 1 week, 1 month, 3 months, 6 months, and 1 year after lens wear. Within-group and between-group differences were analyzed. Results: A total of 116 myopic patients aged 8 to 15 years were enrolled, including 62 in the SV group and 54 in the OK group. After 1 year, AL elongation in the OK group (0.101±0.032 mm) was significantly smaller than that in the SV group (0.393±0.035 mm; P <0.001), and the change in SE (−0.444±0.251 D) was also significantly smaller than that in the SV group (−0.863±0.372 D; P <0.001). Between-group differences in AL emerged from 1 month ( P <0.001), and differences in SE emerged from 3 months ( P <0.001). In the OK group, ChT increased across sectors during the first 1 to 3 months, followed by partial fluctuation and regression thereafter, whereas 3D-CVI generally increased during months 3 to 6 with mild later fluctuation. In the SV group, most sectors showed statistically significant differences, except for the outer inferior sector, but changes lacked a consistent trend; for 3D-CVI, significant differences were observed in several sectors, likewise without a consistent trend. Except at 1 week, increases in ChT and 3D-CVI in almost all macular sectors at subsequent time points were significantly greater in the OK group than in the SV group (most P <0.05). Conclusions: Compared with SV, OK lenses suppress AL elongation and SE progression. There are increases in ChT and 3D-CVI associated with this suppression, suggesting that ChT and 3D-CVI may serve as biomarkers for evaluating the efficacy of myopia-control interventions and supporting further investigation of their role in mechanism of myopia control.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: